# Radiolabeled Monoclonal Antibody With or Without Peripheral Stem Cell Transplantation in Treating Children With Recurrent or Refractory Lymphoma

> **NCT00036855** · PHASE1 · TERMINATED · sponsor: **National Cancer Institute (NCI)** · enrollment: 36 (actual)

## Conditions studied

- AIDS-related Peripheral/Systemic Lymphoma
- AIDS-related Primary CNS Lymphoma
- Post-transplant Lymphoproliferative Disorder
- Recurrent Childhood Large Cell Lymphoma
- Recurrent Childhood Lymphoblastic Lymphoma
- Recurrent Childhood Small Noncleaved Cell Lymphoma
- Recurrent/Refractory Childhood Hodgkin Lymphoma

## Interventions

- **BIOLOGICAL:** rituximab
- **RADIATION:** indium In 111 ibritumomab tiuxetan
- **RADIATION:** yttrium Y 90 ibritumomab tiuxetan
- **PROCEDURE:** peripheral blood stem cell transplantation
- **BIOLOGICAL:** filgrastim
- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT00036855
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2002-06
- **Primary completion:** 2005-03
- **Final completion:** —
- **Target enrollment:** 36 (ACTUAL)
- **Why stopped:** Administratively complete.
- **Last updated:** 2013-01-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00036855

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00036855, "Radiolabeled Monoclonal Antibody With or Without Peripheral Stem Cell Transplantation in Treating Children With Recurrent or Refractory Lymphoma". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00036855. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*